GlassScriptPhysician profile
Kimberly Valenti
NPI 1255716775
$13,952.30
in general payments reported to CMS, 2019-2025
30 companies · $2,653 in 2025
The $2,653 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,092 · 2022: $5,305 · 2023: $1,371 · 2024: $3,532 · 2025: $2,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,502 · Travel and Lodging: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,502.21 |
| Travel and Lodging | $1,053.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,362.01 | 2021-2025 | Watchman Flx, Watchman Access System, Opticross |
| Medtronic, INC. | $2,705.57 | 2022-2025 | Corevalve Evolut R, Pulseselect, Onyx Frontier |
| Abbott Laboratories | $2,696.67 | 2021-2025 | Dragonfly Opstar, Diamondback Coronary, Mitraclip |
| Edwards Lifesciences Corporation | $2,529.19 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $351.46 | 2024-2025 | Impella |
| Shockwave Medical, INC | $328.44 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Atricure, INC. | $323.48 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $299.14 | 2021-2025 | |
| Chiesi USA, INC. | $272.21 | 2021-2025 | Kengreal |
| Cardiva Medical, INC. | $172.25 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.19 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $98.29 | 2024-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $86.83 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $84.45 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $58.45 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $55.96 | 2021 | |
| Alnylam Pharmaceuticals INC. | $50.58 | 2025 | Onpattro |
| Stryker Corporation | $40.64 | 2025 | Flowtriever |
| Lexicon Pharmaceuticals, INC. | $40.43 | 2024 | |
| Surmodics, INC. | $33.65 | 2023-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Actelion Pharmaceuticals US, INC. | $31.21 | 2024 | Opsumit |
| Philips North America LLC | $27.24 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Davol INC. | $25.71 | 2025 | |
| Pfizer INC. | $24.78 | 2023 | |
| Recor Medical INC | $23.62 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $21.91 | 2022 | |
| Biotronik INC. | $19.19 | 2022 | |
| Kestra Medical Technology Services, INC. | $14.41 | 2023 | Assure Wcd |
| Cardiofocus, INC. | $14.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Valenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.